Phase II study of gemcitabine/vinorelbine (GV) as first or second line chemotherapy in patients with metastatic soft tissue sarcoma (STS).

被引：0
|
作者：
Morgan, JA [1 ]
George, S [1 ]
Desai, J [1 ]
Amand, MS [1 ]
Horton, D [1 ]
Wilkins, E [1 ]
Manola, J [1 ]
Demetri, GD [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9009
引用
收藏
页码：820S / 820S
页数：1
相关论文
共 50 条
  • [31] Phase I/II study of docetaxel (D), gemcitabine (G), and bevacizumab (B) in patients (pts) with advanced or recurrent soft tissue sarcoma (STS)
    Verschraegen, C. F.
    Quinn, R.
    Rabinowitz, I.
    Arias-Pulido, H.
    Muller, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group
    Nicolaides, C
    Dimopoulos, MA
    Samantas, E
    Bafaloukos, D
    Kalofonos, C
    Fountzilas, G
    Razi, E
    Kosmidis, P
    Pavlidis, N
    ANNALS OF ONCOLOGY, 2000, 11 (07) : 873 - 875
  • [33] Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma
    Kim, Jee Hung
    Park, Hyung Soon
    Heo, Su Jin
    Kim, Sang Kyum
    Han, Jung Woo
    Shin, Kyoo-Ho
    Kim, Seung Hyun
    Hur, Hyuk
    Kim, Kyung Sik
    Choi, Young Deuk
    Kim, Sunghoon
    Lee, Young Han
    Suh, Jin-Suck
    Ahn, Joong-Bae
    Chung, Hyun Cheol
    Noh, Sung Hoon
    Rha, Sun Young
    Kim, Hyo Song
    ONCOLOGY, 2019, 96 (02) : 59 - 69
  • [34] Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas
    Maki, Robert G.
    Wathen, J. Kyle
    Patel, Shreyaskumar R.
    Priebat, Dennis A.
    Okuno, Scott H.
    Samuels, Brian
    Fanucchi, Michael
    Harmon, David C.
    Schuetze, Scott M.
    Reinke, Denise
    Thall, Peter F.
    Benjamin, Robert S.
    Baker, Laurence H.
    Hensley, Martee L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) : 2755 - 2763
  • [35] Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: Phase II study
    Lee, S
    Lee, E
    Jeong, H
    Lee, S
    Kim, J
    Shin, C
    Shim, J
    Kang, K
    Yoo, S
    In, K
    LUNG CANCER, 2005, 49 : S255 - S255
  • [36] Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer
    Park, In Hae
    Ro, Jungsil
    Lee, Keun Seok
    Kim, Shi Nae
    Yun, Young Ho
    Nam, Byung Ho
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (05) : 659 - 669
  • [37] Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study
    Emilio Esteban
    Joaquin Fra
    Yolanda Fernández
    Norberto Corral
    José M. Vieitez
    Isabel Palacio
    José L. de Sande
    José L. Fernández
    Isabel Muñiz
    Noemi Villanueva
    Enrique Estrada
    Beatriz Mareque
    Esther Uña
    José M. Buesa
    Angel J. Lacave
    Investigational New Drugs, 2006, 24 : 241 - 248
  • [38] Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer
    In Hae Park
    Jungsil Ro
    Keun Seok Lee
    Shi Nae Kim
    Young Ho Yun
    Byung Ho Nam
    Investigational New Drugs, 2010, 28 : 659 - 669
  • [39] Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer:: Results of a prospective randomized phase II study
    Esteban, E
    Fra, J
    Fernández, Y
    Corral, N
    Vieitez, JM
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (03) : 241 - 248
  • [40] A randomized phase II study of gemcitabine with vinorelbine (GV) vs. sequential gemcitabine and vinorelbine (G/V) in metastatic breast cancer (MBC): An interim analysis.
    Lee, Keun Seok
    Lim, Hyeong-Seok
    Kwon, Hye Soo
    Nam, Byung-Ho
    Ro, Jungsil
    CANCER RESEARCH, 2006, 66 (08)
12345